Veracyte, Inc.
Nasdaq VCYT · South San Francisco, CA
Works in Oncology · Respiratory
Veracyte, Inc. is a clinical trial sponsor based in South San Francisco, CA, listed as Nasdaq VCYT. It has 1 active clinical trial with 2,400 planned participants, in Oncology and Respiratory.
Trial track record · since 2021
Financials · Nasdaq VCYT
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Veracyte, Inc
Veracyte, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 2,400 planned participants, in Oncology, Respiratory. Since 2021 it has completed 0 trials and stopped 0 early.
Veracyte, Inc is based in South San Francisco, CA and is listed as Nasdaq VCYT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Veracyte, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-11-13.
Approve Suite is not affiliated with Veracyte, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.